These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 21667029

  • 1. Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.
    Qi X, Song X, Liu P, Yi T, Li S, Xie C, Zheng Y, Bai Y, Sun C, Wei Y, Zhao X.
    Oncol Rep; 2011 Sep; 26(3):703-10. PubMed ID: 21667029
    [Abstract] [Full Text] [Related]

  • 2. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
    Liu P, Gou M, Yi T, Qi X, Xie C, Zhou S, Deng H, Wei Y, Zhao X.
    Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
    [Abstract] [Full Text] [Related]

  • 3. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
    Yang F, Li Z, Deng H, Yang H, Yan F, Qian Z, Chen L, Wei Y, Zhao X.
    Oncology; 2008 Oct; 75(3-4):137-44. PubMed ID: 18824876
    [Abstract] [Full Text] [Related]

  • 4. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [Abstract] [Full Text] [Related]

  • 5. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M, Bhatnagar P, Mishra S, Kumar P, Shukla Y, Gupta KC.
    Int J Nanomedicine; 2015 Dec; 10():6789-809. PubMed ID: 26586942
    [Abstract] [Full Text] [Related]

  • 6. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
    Zou L, Song X, Yi T, Li S, Deng H, Chen X, Li Z, Bai Y, Zhong Q, Wei Y, Zhao X.
    Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823
    [Abstract] [Full Text] [Related]

  • 7. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
    Li D, Zhang Y, Xie Y, Xiang J, Zhu Y, Yang J.
    Cancer Gene Ther; 2013 Apr; 20(4):251-9. PubMed ID: 23470565
    [Abstract] [Full Text] [Related]

  • 8. Expression of hPNAS-4 radiosensitizes Lewis lung cancer.
    Zeng H, Yuan Z, Zhu H, Li L, Shi H, Wang Z, Fan Y, Deng Q, Zeng J, He Y, Xiao J, Li Z.
    Int J Radiat Oncol Biol Phys; 2012 Nov 15; 84(4):e533-40. PubMed ID: 22836062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.
    Guo S, Lin CM, Xu Z, Miao L, Wang Y, Huang L.
    ACS Nano; 2014 May 27; 8(5):4996-5009. PubMed ID: 24720540
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
    Jiang QQ, Fan LY, Yang GL, Guo WH, Hou WL, Chen LJ, Wei YQ.
    BMC Cancer; 2008 Aug 16; 8():242. PubMed ID: 18706101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D, Williams JI, Pietras RJ.
    Oncogene; 2002 Apr 25; 21(18):2805-14. PubMed ID: 11973639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb 25; 51(2):126-34. PubMed ID: 26917482
    [Abstract] [Full Text] [Related]

  • 19. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.
    Cancer Res; 2018 Nov 01; 78(21):6247-6256. PubMed ID: 30115698
    [Abstract] [Full Text] [Related]

  • 20. A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells.
    Bai MY, Liu SZ.
    Colloids Surf B Biointerfaces; 2014 May 01; 117():346-53. PubMed ID: 24681046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.